Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06426485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets

Name: To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets — clinical trial record (NCT06426485)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorLuye Pharma Group Ltd.

Started2024-05-30

View on ClinicalTrials.gov ↗

Luye Pharma Group Ltd.

16 trials monitored

See all monitored trials

Depression

2,976 trials monitored

See 162 trials at risk

This is a multicenter, randomized withdrawal, double-blind, parallel, placebo-controlled design clinical trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets to evaluate the long-term efficacy and safety in the treatment of Chinese patients with depression.

Trial Details

NCT Number	NCT06426485
Lead Sponsor	Luye Pharma Group Ltd.
Conditions	Major Depressive Disorder
Enrollment	736 participants
Start Date	2024-05-30
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2024-05-23